Securities code: 600781 securities abbreviation: St Furen Announcement No.: 2021-063
Furen Group Pharmaceutical Co.Ltd(600781)
Announcement on the results of shareholders’ share reduction
The board of directors, all directors and relevant shareholders of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents. Important content tips:
Basic information of major shareholders and directors, supervisors and senior executives: Furen Group Pharmaceutical Co.Ltd(600781) (hereinafter referred to as “the company”) major shareholder Shenzhen pingjiaxinyuan equity investment partnership (limited partnership) (hereinafter referred to as “pingjiaxinyuan”) holds 41148947 shares of the company, accounting for 6.56% of the total shares of the company. On June 1, 2021, pingjiaxinyuan disclosed Furen Group Pharmaceutical Co.Ltd(600781) through the company Announcement of share reduction plan by shareholders: within 6 months after 15 trading days from the date of announcement of share reduction plan, Ping Jiaxinyuan’s total number of shares reduced through competitive trading shall not exceed 12543150 shares, that is, not more than 2% of the total shares of the company, and the total number of shares reduced within any continuous 90 natural days shall not exceed 1% of the total shares of the company; The number of shares reduced through block trading shall not exceed 25086300 shares, that is, not more than 4% of the total shares of the company, and the total number of shares reduced within any continuous 90 natural days shall not exceed 2% of the total shares of the company.
Implementation results of the share reduction plan: the company received the notification letter on the implementation progress of share reduction from Ping Jiaxinyuan. From June 30, 2021 to December 3, 2021, Ping Jiaxinyuan reduced 7750800 shares of the company through the centralized bidding trading system of Shanghai Stock Exchange, accounting for 1.23% of the total share capital of the company.
1、 Basic information of the reducing entity before the reduction
Number of shares held
Shareholder name shareholder identity shareholding proportion current shareholding source (shares)
Shenzhen pingjiaxinyuan
More than 5% of the assets purchased by non first issue shares are taken as 411489476.56% of equity investment partnership enterprises
Major shareholders: 41148947 shares
Business (limited partnership)
The above reduction subjects have no concerted action.
2、 Implementation results of share reduction plan (I) major shareholders and directors, supervisors and senior executives disclose the implementation results of share reduction plan due to the following matters:
The disclosed reduction time interval expires
Reduction price
Reduction quantity reduction ratio reduction party interval reduction total amount reduction completed current number of shares current shareholder name reduction period
(share) example formula (yuan / (yuan) situation (share) proportion (share)
Shenzhen pingjiaxin
2.84-yuan equity investment from June 30, 2021 to centralized competition
77508001.23% 25202359.72 completed 333981475.33% partnership (limited 2021 / 12 / 3 price transaction 4.53
Partnership)
（2） Whether the actual reduction is consistent with the previously disclosed reduction plan and commitment √ yes □ no (III) whether the reduction time interval expires and whether the reduction has not been implemented □ not implemented √ implemented
（4） Whether the actual reduction has not reached the minimum reduction quantity (proportion) of the reduction plan □ not reached √ reached (V) whether the reduction plan has been terminated in advance □ yes √ no
It is hereby announced.
Furen Group Pharmaceutical Co.Ltd(600781) board of directors 2021 / 12 / 24
